ICRA has assigned its long term rating of [ICRA]BB+ (pronounced ICRA double B plus) to the Rs. 19.90
crore bank facilities of Uni Medicolabs (UML) The outlook on the long-term rating is ‘Stable’.
The assigned rating takes into account the long experience of the promoters in the pharmaceutical
business being API distributors and suppliers and established relations with key pharmaceutical
companies in domestic market. As a pharmaceutical contract manufacturer, UML started operations in
2009 initially operating as a loan licensee and having shifted to Principal to Principal model (P2P)
supplies in 2013-14. Although the firm has been able to ramp up its capacity utilization for the capsules
and injectables facility, its utilization for the tablets and dry syrups remains moderate. The available
capacity as well as new orders from customers is expected to drive sales growth of the firm in the near
term.
Vacancy Details
Officer / Executive – Analytical QA
Officer / Executive – Qualification
Stability Officer
Officer / Executive Documentation
Officer – IPQA
Date: 13-02-2022
Venue : UNI MEDICOLABS, DEHRADUN, Plot No. 21-22, Pharmacity Selaqui Dehradun-248011, Uttarakhand, India
Contact to HR: +91-9258022611/+91-9068557631
The admission process for the 2026-2027 academic year is about to begin in Kasturba Gandhi…
An inter-ministerial briefing on the recent developments in West Asia was organised at the National…
On 1stNovember, 2024, the Andhra Pradesh government has launched the Deepam 2.0 scheme, providing three…
Amazon.com strives to be Earth's most customer-centric company where people can find and discover virtually…
Tata Consultancy Services is an IT services, consulting and business solutions organization that has been…
Founded by Mr Jaidayal Dalmia in 1939, Dalmia Cement is one of India€™s pioneering homegrown…